NASDAQ
Omnicell, Inc. (OMCL)
♥ 507 Thanks from members
Omnicell (OMCL) shares face a 20.1% monthly pullback despite an upgraded 2026 EPS and revenue outlook, driven by strong Q2 results, operating discipline, and a one-time tariff refund, countered by lingering concerns over memory-chip costs, bookings timing, and hospital purchasing visibility.